Molecular Therapy

Molecular Therapy Family's Impact Factor Increased 44 Percent in 2020

ASGCT Staff | July 01, 2021

Molecular Therapy-Oncolytics' 75% increase, to 7.200, was the highest impact factor jump across more than 50 Cell Press journals.

Molecular Therapy
Read Full Story

Meet the Editor: Gerhard Bauer, Molecular Therapy—Methods & Clinical Development

ASGCT Staff | November 25, 2019

ASGCT member and director of the Good Manufacturing Practice (GMP) laboratory at the UC Davis Institute for Regenerative Cures Gerhard Bauer will become the editor-in-chief of ASGCT's journal, Molecular Therapy—Methods & Clinical Development on January 1, 2020.

Molecular Therapy
Read Full Story

ASGCT member and Indiana University professor of pediatrics Roland W. Herzog, Ph.D. will become the editor-in-chief of ASGCT's field-leading journal, Molecular Therapy, on January 1, 2020.

Meet the Editor: Roland W. Herzog, Ph.D., Editor-in-Chief of Molecular Therapy

ASGCT Staff | November 25, 2019

ASGCT member and Indiana University professor of pediatrics Roland W. Herzog, Ph.D. will become the editor-in-chief of ASGCT's field-leading journal, Molecular Therapy, on January 1, 2020.

Molecular Therapy
Read Full Story

Herzog and Bauer will assume their roles as editors-in-chief of ASGCT’s Molecular Therapy and Molecular Therapy—Methods & Clinical Development, respectively, on January 1.

Molecular Therapy Family of Journals Welcomes Two Editors-in-Chief

ASGCT Staff | November 25, 2019

Herzog and Bauer will assume their roles as editors-in-chief of ASGCT’s Molecular Therapy and Molecular Therapy—Methods & Clinical Development, respectively, on January 1.

Molecular Therapy
Read Full Story

A New AAV Vector Can Efficiently Target the Brains of Mice Through IV Injection

Killian S. Hanlon, Eloise Hudry, and Casey A. Maguire | November 22, 2019

Researchers have developed this new tool for genetically modifying the brains of mice, and experiments in non-human primates are currently underway.

Molecular Therapy
Read Full Story

Molecular Therapy Impact Factors Jump Nearly 28 Percent Across Family of Titles

ASGCT Staff | June 26, 2019

Parent journal, Molecular Therapy, now tops the field with a 19.9 percent jump in impact factor to 8.402.

ASGCT News   |   Molecular Therapy
Read Full Story

The Molecular Therapy app offers subscribers full access to the Molecular Therapy family of journals on Apple and Android devices.

ASGCT’s Launch Month Continues: Molecular Therapy App & 2018 Annual Meeting Website

ASGCT Staff | October 24, 2017

Even before ASGCT launched a redesigned website last week, Society members were celebrating the release of a standalone app for the Molecular Therapy family of journals and unveiling the website for the 21st Annual Meeting.

ASGCT News   |   Molecular Therapy   |   Technologies
Read Full Story
2021

ASGCT Policy Summit

September 22-24, 2021

This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.